The risk reduction observed under treatment with the other ACE inhibitors was nearly statistically significant (−22%; HR=0.78, 0.60 to 1.02; p=0.072).
← all excerpts
Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies.
1
0.0720
0.0720